Clinical Trial: A Clinical Study of Rapamycin for the Treatment of Poor Platelet Recollection Following Allogeneic Hematopoietic Stem Cell Transplantation (China)

Posted On: 2026-10-26

China, Oct. 26 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Clinical Study of Rapamycin for the Treatment of Poor Platelet Recollection Following Allogeneic Hematopoietic Stem Cell Transplantation'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135061

Registration Time: 2026/10/23

Type: Observational study

Primary Sponsor: The First Affiliated Hospital of Guangxi Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=346552

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A Clinical Study of Rapamycin for the Treatment of Poor Platelet Recollection Following Allogeneic Hematopoietic Stem Cell Transplantation (China)